None listed
Conditions
Brief summary
Previous research has shown that micronutrients can reduce stress associated with natural disasters (earthquakes, floods). It has not been established whether micronutrients can assist people who are victims of a massacre. This study intends to provide micronutrients to people who were either present in one of the mosques in Christchurch on March 15th 2019 or know someone who was in one of the mosques.
Interventions
This study is an open label pre post design whereby we will give micronutrients for 6 weeks to people who have been victims of the mosque shooting in Christchurch.
Participants will be asked to consume 3 pills twice a day. Total dose per day is:
Vitamin A (as retinyl palmitate) 4000.0 IU
Vitamin C (as ascorbic acid) 300.0 mg
Vitamin D (as cholecalciferol) 3000.0 IU
Vitamin E (as d-alpha tocopheryl succinate) 70 IU
Vitamin K1 (as phylloquinone & menaquinone-7) 120.0 mcg
Thiamin (as thiamin mononi
This study is an open label pre post design whereby we will give micronutrients for 6 weeks to people who have been victims of the mosque shooting in Christchurch. Participants will be asked to consume 3 pills twice a day. Total dose per day is: Vitamin A (as retinyl palmitate) 4000.0 IU Vitamin C (as ascorbic acid) 300.0 mg Vitamin D (as cholecalciferol) 3000.0 IU Vitamin E (as d-alpha tocopheryl succinate) 70 IU Vitamin K1 (as phylloquinone & menaquinone-7) 120.0 mcg Thiamin (as thiamin mononitrate) 54.0 mg Riboflavin 16.0 mg Niacin (as niacinamide) 52.0 mg Vitamin B6 (as pyridoxine hydrochloride) 48.0 mg Folate (as folic acid & L-methylfolate calcium) 800.0 mcg Vitamin B12 (as methylcobalamin) 336.0 mcg Biotin 636.0 mcg Pantothenic acid (as d-calcium pantothenate) 28.0 mg Calcium (as chelate) 606.0 mg Iron (as chelate) – for women 27.0 mg Iron (as chelate) – for men 8.0 mg Phosphorus (as chelate) 386.0 mg Iodine (as chelate) 240.0 mcg Magnesium (as chelate) 274.0 mg Zinc (as chelate) 22 mg Selenium (as chelate) 92.0 mcg Copper (as chelate) 3.2 mg Manganese (as chelate) 4.4 mg Chromium (as chelate) 286 mcg Molybdenum (as chelate) 66.0 mcg Potassium (as chelate) 110.0 mg Other ingredients (doses not provided as proprietary blend): Choline, coenzyme Q10, beta sitosterol, tocopherol, Mineral wax, Spirulina, Larch arabinogalactan, Inositol, Rhodiola rosea root extract, alpha lipoic extract, bamboo shoot extract, Astragalus root extract, Royal jelly, Grape seed extract, Ginkgo biloba leaf extract, Boron (as chelate), Vanadium (as chelate), Lithium orotate (as chelate), Nickel (as chelate)vegetarian capsule, microcrystalline cellulose, magnesium stearate, silicon dioxide, Extra for men: saw palmetto fruit extract Participants will be asked to tell us number of missed doses every two weeks and also after 4 weeks, how many pills are remaining in the bottle.
Sponsors
Julia Rucklidge
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Inclusion criteria: Participants must be a victim of the mosque shooting – either present in one of the mosques or know someone who was in the mosque. Further, they must be over 18 years of age, possess a level of understanding sufficient to complete the questionnaires and examinations required by the protocol and be considered reliable and compliant with the protocol (including the ingestion of as many as 6 capsules/day), and must be able to eat at least a snack twice per day. They must self identify as struggling with psychological symptoms as a consequence of the Christchurch events.
Exclusion criteria
Exclusion criteria: 1) Neurological disorder involving brain or other central function (e.g., epilepsy, MS, narcolepsy), 2) Any serious medical condition, 3) Any participant known to be allergic to the ingredients of the intervention, 4) Evidence of untreated or unstable thyroid disease, 5) Any known abnormality of mineral metabolism (e.g., Wilson’s disease, haemochromatosis), 6) evidence of substance dependence within the previous month, 7) Any participant judged clinically to be at serious risk for suicide or violence in the opinion of the researchers.
Outcome results
None listed